Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
BMJ Open Gastroenterology|December 29, 2020
Prevention of hepatic encephalopathy by administration of rifaximin and lactulose in patients with liver cirrhosis undergoing placement of a transjugular intrahepatic portosystemic shunt (TIPS): a multicentre randomised, double blind, placebo controlled trial (PEARL trial)K de Wit, J J Schaapman, F Nevens, et al.
The Netherlands Journal of Medicine|October 17, 2014
Hepatocellular carcinoma: Dutch guideline for surveillance, diagnosis and therapyF A L M Eskens, K J van Erpecum, K P de Jong, et al.
The British Journal of Surgery|July 18, 2019
Safety and efficacy of transarterial embolization of hepatocellular adenomasB V van Rosmalen, A J Klompenhouwer, J Jaap de Graeff, et al.
Scandinavian Journal of Gastroenterology|January 9, 2026
The impact of biliary drainage on chemotherapy initiation and survival in patients with non-resected perihilar cholangiocarcinoma: a population-based study in the NetherlandsD M de Jong, E van Ette, L G van der Geest, et al.
BMC Cancer|May 9, 2025
Primary percutaneous stenting above the ampulla versus endoscopic drainage for unresectable malignant hilar biliary obstruction (TESLA RCT): study protocol for a multicenter randomized controlled trialM Rousian, V van Verschuer, S Franssen, et al.
BMC Cancer|April 7, 2019
Adjuvant hepatic arterial infusion pump chemotherapy and resection versus resection alone in patients with low-risk resectable colorectal liver metastases - the multicenter randomized controlled PUMP trialF E Buisman, M Y V Homs, D J Grünhagen, et al.
Trials|April 30, 2021
Radiofrequency ablation and chemotherapy versus chemotherapy alone for locally advanced pancreatic cancer (PELICAN): study protocol for a randomized controlled trialM S Walma, S J Rombouts, L J H Brada, et al.
Cardiovascular and Interventional Radiology|July 5, 2022
Dragon 1 Protocol Manuscript: Training, Accreditation, Implementation and Safety Evaluation of Portal and Hepatic Vein Embolization (PVE/HVE) to Accelerate Future Liver Remnant (FLR) HypertrophyR Korenblik, B Olij, L A Aldrighetti, et al.
Pageof 5